Get the Stockscreener App
2.39
2.45%
-0.06
After Hours:
2.40
0.010
+0.42%
China Sxt Pharmaceuticals Inc stock is traded at $2.39, with a volume of 16,848.
It is down -2.45% in the last 24 hours and up +65.97% over the past month.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
See More
Previous Close:
$2.45
Open:
$2.47
24h Volume:
16,848
Relative Volume:
0.21
Market Cap:
$10.65M
Revenue:
$1.54M
Net Income/Loss:
$-8.87M
P/E Ratio:
-0.0673
EPS:
-35.4915
Net Cash Flow:
$-2.74M
1W Performance:
+17.73%
1M Performance:
+65.97%
6M Performance:
-99.06%
1Y Performance:
-99.15%
1-Day Range:
$2.2371
$2.47
1-Week Range:
$2.00
$2.6999
52-Week Range:
$1.2501
$1,046.98
China Sxt Pharmaceuticals Inc Stock (SXTC) Company Profile
Compare SXTC vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SXTC
China Sxt Pharmaceuticals Inc
|
2.39 | 9.41M | 1.54M | -8.87M | -2.74M | -35.49 |
TAK
Takeda Pharmaceutical Co Adr
|
16.89 | 50.65B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.72 | 41.09B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.29 | 39.45B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
75.42 | 30.13B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
547.25 | 23.00B | 3.17B | 1.29B | 1.01B | 27.09 |
China Sxt Pharmaceuticals Inc Stock (SXTC) Latest News
China SXT (NASDAQ: SXTC) 20-F outlines VIE, dual-class shares and China risk - Stock Titan
China SXT Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended March 31, 2026 - marketscreener.com
Enterprise value to EBITDA forward of China SXT Pharmaceuticals, Inc. – NASDAQ:SXTC - TradingView
Price to sales forward of China SXT Pharmaceuticals, Inc. – NASDAQ:SXTC - TradingView
Enterprise value to revenue forward of China SXT Pharmaceuticals, Inc. – NASDAQ:SXTC - TradingView
Price to book forward of China SXT Pharmaceuticals, Inc. – NASDAQ:SXTC - TradingView
Price to earnings forward of China SXT Pharmaceuticals, Inc. – NASDAQ:SXTC - TradingView
Enterprise value to EBIT forward of China SXT Pharmaceuticals, Inc. – NASDAQ:SXTC - TradingView
China SXT Pharmaceuticals Inc (SXTC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
China SXT Pharmaceuticals Inc (SXTC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
China SXT Pharmaceuticals Inc (SXTC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
China SXT Pharmaceuticals Inc (SXTC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
China SXT Pharmaceuticals Inc - TradingKey
China SXT Pharmaceuticals Inc (SXTC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
China SXT Pharmaceuticals Inc (SXTC) Institutional Confidence - TradingKey
China SXT Pharmaceuticals Inc (SXTC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
China SXT Pharmaceuticals Inc (SXTC) Valuation: PE, PB & Fair Value Analysis - TradingKey
China SXT Pharmaceuticals Company Profile & Introduction - Moomoo
China SXT Pharmaceuticals Shares Surge Over 25% After Hours: Here's Why - Sahm
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
China SXT Pharmaceuticals shares surge over 25% after hours: Here's why - MSN
China SXT Pharmaceuticals Launches $100 Million ATM Equity Program with Univest Securities - The Globe and Mail
China SXT Pharmaceuticals (SXTC) launches $100M ATM offering with Univest - Stock Titan
China SXT (NASDAQ: SXTC) sets up $100M at-the-market share offering - Stock Titan
SXTCChina SXT Pharmaceuticals Inc Stock Price and Quote - Finviz
China SXT Pharmaceuticals (SXTC) Surges 7%: Potential Breakout Above ResistanceTriple MA Cross - newsline.com
China SXT Pharmaceuticals (SXTC) Slips 3% as Stock Tests Key Support LevelsLow Volume Node - newsline.com
SXTC Faces Selling Pressure: Key Levels to Watch After 7.3% DeclineStraddle Setup - newsline.com
China SXT Pharmaceuticals (SXTC) Sees Uptick Amid Support HoldingVolume Rate Change - Newser
SXTC Should I Buy - Intellectia AI
TradingKey - TradingKey
SXTC Technical Analysis | Trend, Signals & Chart Patterns | CHINA SXT PHARMACEUTICALS-A (NASDAQ:SXTC) - ChartMill
China SXT Pharmaceuticals Raises $3.5 Million in Offshore Private Placement - The Globe and Mail
China SXT Pharmaceuticals Inc (SXTC) - MSN
China SXT (NASDAQ: SXTC) prices $3.5M Reg S share and warrant deal - Stock Titan
MSN Money - MSN
SXTC Stock Price, Quote & Chart | CHINA SXT PHARMACEUTICALS-A (NASDAQ:SXTC) - ChartMill
What guidance trend China SXT (SXTC)? (Bearish Momentum) 2026-04-29Volume Breakout - newser.com
China SXT Pharmaceuticals (SXTC) Co-CEO reports indirect Class B stake - Stock Titan
China SXT Pharmaceuticals (SXTC) CFO listed as insider in Form 3 - Stock Titan
China SXT Pharmaceuticals (SXTC) director Chee Yong Lip files Form 3 - Stock Titan
Director Ji Xiaodong files Form 3 for China SXT (SXTC) - Stock Titan
Director Liu Tong Tony files Form 3 at China SXT (SXTC) - Stock Titan
Co-CEO Simon Lim listed in China SXT (SXTC) Form 3 with no trades - Stock Titan
[Form 3] China SXT Pharmaceuticals, Inc. Initial Statement of Beneficial Ownership - Stock Titan
China SXT (SXTC) Sector Leadership | Q1 2025: Earnings ReportCommunity Sell Signals - Xã Thanh Hà
China SXT (SXTC) Stock: Why Industry Position (Bullish Sentiment) 2026-04-22Cash Flow - Cổng thông tin điện tử tỉnh Lào Cai
China SXT (SXTC) Stock Days to Cover (Smart Money Exits) 2026-04-15Crowd Risk Alerts - Cổng thông tin điện tử tỉnh Tây Ninh
Form 424B5Prospectus [Rule 424(b)(5)] - ADVFN
China SXT Pharmaceuticals Raises $760,000 in Registered Share Offering - The Globe and Mail
China SXT Pharmaceuticals announces $760,000 share offering on Monday By Investing.com - Investing.com India
China Sxt Pharmaceuticals Inc Stock (SXTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.03%
0.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):